IL-6 plays a dual role: while acutely anti-inflammatory via STAT3, chronic elevation in obesity promotes hepatic acute-phase responses [29,31] and synergizes with IL-1β to induce β-cell endoplasmic reticulum (ER) stress [28]. Here, IL6 is linked to obesity disorder.